0001562180-19-001487.txt : 20190228 0001562180-19-001487.hdr.sgml : 20190228 20190228172424 ACCESSION NUMBER: 0001562180-19-001487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190226 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reine Allan CENTRAL INDEX KEY: 0001714023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37471 FILM NUMBER: 19645004 MAIL ADDRESS: STREET 1: C/O PIERIS PHARMACEUTICALS, INC. STREET 2: 255 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001583648 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 300784346 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 255 STATE STREET STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-246-8998 MAIL ADDRESS: STREET 1: 255 STATE STREET STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Marika Inc. DATE OF NAME CHANGE: 20130805 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-02-26 false 0001583648 PIERIS PHARMACEUTICALS, INC. PIRS 0001714023 Reine Allan C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109 false true false false Chief Financial Officer Stock Options (Right to Buy) 3.09 2019-02-26 4 A false 162500.00 0.00 A 2029-02-26 Common Stock 162500.00 162500.00 D The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. /s/ Marc D. Mantell, Attorney-in-fact 2019-02-28